APA

Okanny C. C., Durosimi M. A., Chukwuani C. M., Njoku O. S., Akinola N. O., Herrada S. C., Ogbe O. P., Onwukeme K. E., Faluyi J. O., Akanmu A. S. & Akinsete I. (20010628). Interferon alfa-2a (Roferon-A) monotherapy in chronic myelogenous leukemia: a pilot study in Nigerian patients in early chronic phase. : West African journal of medicine.

Chicago

Okanny C C, Durosimi M A, Chukwuani C M, Njoku O S, Akinola N O, Herrada S C, Ogbe O P, Onwukeme K E, Faluyi J O, Akanmu A S and Akinsete I. 20010628. Interferon alfa-2a (Roferon-A) monotherapy in chronic myelogenous leukemia: a pilot study in Nigerian patients in early chronic phase. : West African journal of medicine.

Harvard

Okanny C. C., Durosimi M. A., Chukwuani C. M., Njoku O. S., Akinola N. O., Herrada S. C., Ogbe O. P., Onwukeme K. E., Faluyi J. O., Akanmu A. S. and Akinsete I. (20010628). Interferon alfa-2a (Roferon-A) monotherapy in chronic myelogenous leukemia: a pilot study in Nigerian patients in early chronic phase. : West African journal of medicine.

MLA

Okanny C C, Durosimi M A, Chukwuani C M, Njoku O S, Akinola N O, Herrada S C, Ogbe O P, Onwukeme K E, Faluyi J O, Akanmu A S and Akinsete I. Interferon alfa-2a (Roferon-A) monotherapy in chronic myelogenous leukemia: a pilot study in Nigerian patients in early chronic phase. : West African journal of medicine. 20010628.